MENU
AKBA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Akebia Therapeutics (AKBA) Ownership - Who owns Akebia Therapeutics?
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
595.61M
P/E Ratio
N/A
Total Cash
51.87M
Projected Growth
N/A
Total Debt
47.64M
Revenue
160.18M
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash/Share
0.20
Total Debt/Equity
N/A
Revenue/Share
0.76 USD as % of share price
Fundamentals
AKBA
Capitalization
596M
P/E Ratio
N/A
Risk (Beta)
0.67
Dividend Yield
N/A
Total Cash
51.9M
Total Cash/Share
0.20
Total Debt
47.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.76%
Revenue
160M
ROE
N/A
Book Value
-49.19M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.33
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
1.41
Current Revenue Per Employee
278425.16
Dividends Per Share - Security
N/A
EBITDA
-13.72M
Float
N/A
Float - Current
N/A
Gross Income Margin
56.20
Revenue To Assets
-30.02
Shares Held By Institutions
234M
Shares Outstanding - Current
261M
Total Liabilities
270M
Total Volume MTD
N/A
Value
-1
Gain YTD
13.684
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of drugs for the treatment of anemia and vascular diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com